Home > Annual Financials > SAKAR HEALTHCARE

SAKAR HEALTHCARE Financial Statement Analysis
[NSE : SAKAR]

The Revenues of SAKAR HEALTHCARE have increased by 14.99% YoY .
The Earnings Per Share (EPS) of SAKAR HEALTHCARE has increased by 48.42 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

SAKAR HEALTHCARE Last 5 Annual Financial Results
[NSE : SAKAR]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹153 Cr₹133 Cr₹128 Cr₹95 Cr₹8,298,024 Cr
Expenses ₹115 Cr₹100 Cr₹99 Cr₹72 Cr₹6,343,119 Cr
Operating Profit (Excl OI) ₹38 Cr₹33 Cr₹29 Cr₹23 Cr₹1,954,905 Cr
Other Income ₹3.18 Cr₹4.68 Cr₹2.17 Cr₹1.18 Cr₹201,684 Cr
Interest ₹7.62 Cr₹5.96 Cr₹2.91 Cr₹2.50 Cr₹225,918 Cr
Depreciation ₹18 Cr₹15 Cr₹9.67 Cr₹8.06 Cr₹707,981 Cr
Profit Before Tax ₹16 Cr₹17 Cr₹19 Cr₹13 Cr₹1,222,691 Cr
Profit After Tax ₹12 Cr₹13 Cr₹15 Cr₹11 Cr₹962,285 Cr
Consolidated Net Profit ₹12 Cr₹13 Cr₹15 Cr₹11 Cr₹962,285 Cr
Earnings Per Share (Rs)₹7.97₹5.37₹6.70₹8.87₹6.84
PAT Margin (%)9.867.619.5711.8411.28
ROE(%)6.485.428.4813.4411.88
ROCE(%)8.437.428.9512.0913.16
Total Debt/Equity(x)0.310.310.690.730.43

Key Financials

Market Cap : ₹ 830.5 Cr
Revenue (TTM) : ₹ 204.0 Cr
Net Profit(TTM) : ₹ 19.5 Cr
EPS (TTM) : ₹ 8.7
P/E (TTM) : 42.6

Industry Peers & Returns1W1M1Y
SAKAR HEALTHCARE -8% 2.1% 34.5%
SUN PHARMACEUTICAL INDUSTRIES 0.9% 5.3% 1.8%
DIVIS LABORATORIES -2.3% -3.3% 12.2%
CIPLA -1.6% -9.2% 4.4%
TORRENT PHARMACEUTICALS -3.3% 2.8% 19.7%
DR REDDYS LABORATORIES NA -3.5% 4.6%
MANKIND PHARMA -0.1% -8.3% -14%
ZYDUS LIFESCIENCES -1.1% -7.5% -1.8%
LUPIN -1.1% 4.4% -0.2%


SAKAR HEALTHCARE Revenues
[NSE : SAKAR]

Y-o-Y

14.99 %

5 Yr CAGR

-93.44 %

Years Revenues % Change
Mar2025 ₹153 Cr
14.99
Mar2024 ₹133 Cr
4.00
Mar2023 ₹128 Cr
35.35
Mar2022 ₹95 Cr
-100.00
Mar2021 ₹8,298,024 Cr -


SAKAR HEALTHCARE Operating Profit
[NSE : SAKAR]

Y-o-Y

15.40 %

5 Yr CAGR

-93.34 %

Years Operating Profit % Change
Mar2025 ₹38 Cr
15.40
Mar2024 ₹33 Cr
13.39
Mar2023 ₹29 Cr
29.75
Mar2022 ₹23 Cr
-100.00
Mar2021 ₹1,954,905 Cr -

Operating Margins
Y-o-Y

0.36 %

5 Yr CAGR

1.52 %

Years Operating Margin% % Change
Mar2025 25.03%
0.36
Mar2024 24.94%
9.00
Mar2023 22.88%
-4.15
Mar2022 23.87%
1.32
Mar2021 23.56% -

SAKAR HEALTHCARE Profit After Tax
[NSE : SAKAR]

Y-o-Y

-8.53 %

5 Yr CAGR

-94.10 %

Years Profit After Tax % Change
Mar2025 ₹12 Cr
-8.53
Mar2024 ₹13 Cr
-15.95
Mar2023 ₹15 Cr
42.09
Mar2022 ₹11 Cr
-100.00
Mar2021 ₹962,285 Cr -

PAT Margins
Y-o-Y

29.57 %

5 Yr CAGR

-3.31 %

Years PAT Margin(%) % Change
Mar2025 9.86 %
29.57
Mar2024 7.61 %
-20.48
Mar2023 9.57 %
-19.17
Mar2022 11.84 %
4.96
Mar2021 11.28 % -

SAKAR HEALTHCARE Earnings Per Share (EPS)
[NSE : SAKAR]

Y-o-Y

48.42 %

5 Yr CAGR

3.90 %

Years EPS % Change
Mar2025 ₹7.97
48.42
Mar2024 ₹5.37
-19.85
Mar2023 ₹6.70
-24.46
Mar2022 ₹8.87
29.68
Mar2021 ₹6.84 -

SAKAR HEALTHCARE Return on Capital Employed (ROCE)
[NSE : SAKAR]

Y-o-Y

13.61 %

5 Yr CAGR

-10.54 %

Years ROCE % Change
Mar2025 8.43%
13.61
Mar2024 7.42%
-17.09
Mar2023 8.95%
-25.97
Mar2022 12.09%
-8.13
Mar2021 13.16% -

SAKAR HEALTHCARE Share Price vs Sensex

Current Share Price : ₹372.4
Current MarketCap: ₹ 830.5 Cr
Updated EOD on :Nov 21,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

-8%

2.1%

34.5%

SENSEX

0.8%

1%

9.9%

SAKAR HEALTHCARE related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about SAKAR HEALTHCARE Financials


How the annual revenues of SAKAR HEALTHCARE have changed ?

The Revenues of SAKAR HEALTHCARE have increased by 14.99% YoY .

How the Earnings per Share (EPS) of SAKAR HEALTHCARE have changed?

The Earnings Per Share (EPS) of SAKAR HEALTHCARE has increased by 48.42 % YoY .